Stock Detail
VIROPHARMA INCORPORATED
Drugs
VPHM @ Yahoo Finance | VPHM Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $22.41 | $22.80 | $0.06 | 0.27% | 0.00 | $22.35 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $22.12 | $21.82 | 997,853 | 1.58B | 912,956.67 | 15.22 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 23.32 | 22.86 | 22.34 | 21.88 | 21.36 |
Stock Profile
ViroPharma Incorporated, a pharmaceutical company, engages in the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. It markets and sells Vancocin Pulvules HCl, the oral capsule formulation, in the United States and its territories. Oral Vancocin is a potent antibiotic to treat antibiotic-associated pseudomembranous and enterocolitis. The company focuses on product development activities on viral diseases, including those caused by cytomegalovirus (CMV) and hepatitis C virus (HCV) infections. Its products under core development program include CMV with an initial focus on CMV infections in recipients of hematopoietic stem cell/bone marrow transplants, and HCV. Noncore development programs target picornaviruses with intranasal pleconaril. The company has strategic relationships with Glaxo SmithKline, Wyeth, Schering-Plough, and Sanofi-Aventis. ViroPharma was incorporated in 1994 and is based in Exton, Pennsylvania.